GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Contribution of Myeloid-Derived Suppressor Cells to Neuro-Inflammatory Alterations and Disease Progression in Glioblastoma

$454,255
Justin D. Lathia · Cleveland Clinic Lerner Com-Cwru · R35 · FY2022 · NS

Novel therapy targeting refractory colon cancer

$454,126
Ping-Ying Pan · Icahn School Of Medicine At Mount Sinai · R01 · FY2016 · CA

Novel therapy targeting refractory colon cancer

$454,126
Ping-Ying Pan · Icahn School Of Medicine At Mount Sinai · R01 · FY2015 · CA

Deregulation of long noncoding RNAs in cancer

$454,095
Nadya M Dimitrova · Yale University · R01 · FY2024 · CA

Project 2: Spatial Architecture of Tumor-Mediated Immunosuppression

$454,052
Garry P Nolan · Stanford University · U54 · FY2019 · CA

Membrane protein target for leukemia therapy

$454,038
Xunlei Kang · University Of Missouri-Columbia · R37 · FY2023 · CA

Project 3: Adaptive immunity to MCPyV in Merkel cell carcinoma

$454,020
David M Koelle · University Of Washington · P01 · FY2022 · CA

Exosome secretion in breast cancer progression

$453,988
Alissa M Weaver · Vanderbilt University · R01 · FY2025 · CA

Targeting glycocalyx-mediated mechanisms of tumor metastasis

$453,981
Lance L Munn · Massachusetts General Hospital · R01 · FY2020 · CA

Targeting glycocalyx-mediated mechanisms of tumor metastasis

$453,981
Lance L Munn · Massachusetts General Hospital · R01 · FY2021 · CA

A Wireless Multi-function Microscope for Lifetime Imaging of the Brain Tumor Vasculome

$453,962
Arvind P Pathak · Johns Hopkins University · R01 · FY2020 · CA

Project 3: Understanding genomic and external drivers of response-predictive inflammatory states underlying differences in clinical outcomes in patients with breast cancer

$453,954
Elad Ziv · University Of California, San Francisco · U54 · FY2025 · CA

Identifying intercellular circuits driving cell phenotypes within a niche

$453,870
Lonnie D Shea · University Of Michigan At Ann Arbor · R01 · FY2020 · CA

Comprehensive characterization of prostate stromal gene expression and association with lethal prostate cancer

$453,851
Kathryn L Penney · Brigham And Women'S Hospital · R37 · FY2023 · CA

Targeted inhibition of eIF5Ahpu suppresses tumor growth and M2-like TAM polarization in oral cancer

$453,848
Anh D Le · University Of Pennsylvania · R01 · FY2023 · DE

Proton-coupled folate/antifolate transport

$453,787
Israel David Goldman · Albert Einstein College Of Medicine, Inc · R01 · FY2017 · CA

Genomics and Computational Biology Shared Resource

$453,745
Kelly A Frazer · University Of California, San Diego · P30 · FY2022 · CA

Regulation of Tumor Metastasis by E-Cadherin Activation and Hippo Signaling

$453,721
Barry M Gumbiner · Seattle Children'S Hospital · R01 · FY2019 · CA

Metastatic Clonal Heterogeneity and its Impact on Melanoma Therapeutic Resistance

$453,702
Willy Hugo · University Of California Los Angeles · R01 · FY2023 · CA

Cancer Genomics and Epigenomics

$453,662
Jean Gautier · Columbia University Health Sciences · P30 · FY2025 · CA

Tumor Biology and Microenvironment Program

$453,662
Michael M. Shen · Columbia University Health Sciences · P30 · FY2025 · CA

Precision Oncology and Systems Biology Program

$453,661
Peter Alan Sims · Columbia University Health Sciences · P30 · FY2025 · CA

Targeting a phosphatidylserine/TAM receptor/PD-L1 axis as a vulnerability in cancer

$453,632
Raymond B Birge · Rutgers Biomedical And Health Sciences · R01 · FY2024 · CA

Pharmacological Blockage of XBP-1s Expression in Cancer

$453,625
Juan R Del Valle · University Of South Florida · R01 · FY2017 · CA

A Novel Target in The Tumor Myeloid Compartment for Hepatocellular Carcinoma

$453,620
Xiang-Yang Wang · Virginia Commonwealth University · P01 · FY2025 · CA